1 / 9

Specialty Generic Drugs Market Size, Share And Forecast To 2028

An increase in the number of off-patent specialty drugs is a factor estimated to form the lucrative growth in the specialty generic drugs market. For instance, the patent for Novartis drug Gilenya is estimated to expire in 2019. This drug has made approximately 14% sales growth of Novartis. Such early patent expirations are expected to boost the global market growth.

priyankauke2013
Télécharger la présentation

Specialty Generic Drugs Market Size, Share And Forecast To 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Specialty Generic Drugs Market Market Size Worth $350.26 Billion By 2028 | CAGR: 25.3%

  2. Specialty Generic Drugs Market Size Worth $350.26 Billion By 2028 “As per Polaris Market Research report, Specialty Generic Drugs market is attending major innovations & transformations and is projected to reach $350.26 Billion By 2028, registering a CAGR of 25.3% during the conjecture period 2021 To 2028.” The global Specialty Generic Drugsmarket report scrutinizes the present situation and development prognosis of the market. The report offers a complete knowledge of key parameters such as market size, share and growth, trends, cost structure, and comprehensive and statistical data in the global Specialty Generic Drugs market. Also, the market overview section of the report holds an in-depth analysis of current and future trends, analyzing the data on a historical basis and forecasted data till the year 2028. The report traces key market drivers, covering potentially lucrative opportunities and challenges as well as drivers, obstacles, issues, and risks. Specialty Generic Drugs Market Report Scope: The global Specialty Generic Drugs market is segmented by product/service type, end-use, and region. The research report analyzes the most important trends related to the different segments that help to explain the market. The report additionally surveys both developed & developing regions considered for global Specialty Generic Drugs market research. The regional analysis engages readers with a comprehensive overview of various countries and regions to help players plan effective expansion strategies. The report outlines the noteworthy factors, such as driving factors and challenges, that will explain the market’s future growth. Also, it covers an exhaustive coverage of major industry drivers, restraints, and their impact on global Specialty Generic Drugs market growth during the forecast period from 2021-2028. The market research assists in studying the key plans, initiatives, and strategies for the development of the market. - 2 -

  3. Specialty Generic Drugs Market Size Worth $350.26 Billion By 2028 By Application By Route of By Distribution By Region Administration Channel •Oncology •Infectious Diseases •Multiple Sclerosis •Hepatitis C •Others •Oral •Parenteral •Topical •Injectable •Others •Retail Pharmacies •Hospital Pharmacies •Online Pharmacies •North America (U.S., Canada) •Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) •Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) •Latin America (Brazil, Mexico, Argentina) •Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) COVID-19 Impact Analysis for Specialty Generic Drugs Market The market has also been affected by the recent COVID-19 pandemic and is expected to experience its long- term effects over the forecast period. Extensive evaluation of the effect of the COVID-19 pandemic is given to uncover the major issues and potential paths forward. The report merges the customer spending habits, business target, dynamics of current market forces, re-routing of the supply chain, and competitors in the global Specialty Generic Drugs market as a thorough analysis. The report serves overall estimation, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Specialty Generic Drugs market across different regions and how major players are building strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities Regional Outlook In terms of geography, the region dominated the market with its higher revenue share contribution. The driving factors for this regional market growth include the current technological advancements in the industry, growing economic stability, huge government investments, and rising awareness related to the benefits of the product/service. Browse Detailed Research Report On Specialty Generic Drugs Market Analysis: https://www.polarismarketresearch.com/industry-analysis/global-specialty-generic-drugs-market - 3 -

  4. Specialty Generic Drugs Market Size Worth $350.26 Billion By 2028 Competitive Landscape The report completely profiles prominent market players or industrialists covering company profile, product specifications, production capacity/sales, revenue, price, and gross margin & sales. Here you will find a comprehensive analysis of the competitive landscape and detailed information on vendors and factors that will challenge the growth of major vendors. The section highlights key points such as regional segmentation, major investments, and details of historical, present, and projected revenues. the product portfolio, market explanation, and classification are indicated. According to Polaris Market Research, the leading players with a noteworthy dominance in the Specialty Generic Drugs market include Valeant Pharmaceuticals International Inc., Endo Pharmaceuticals Inc., Pfizer Inc., Mylan N.V., Teva Pharmaceuticals USA, Inc., Sandoz International GmbH, Mallinckrodt, Akorn Inc., Apotex Corp, and Sun Pharmaceutical Industries Ltd. Request for sample: https://www.polarismarketresearch.com/industry-analysis/global-specialty-generic-drugs- market/request-for-sample Table of Contents 1.Overview and Scope 1.1.Research goal & scope 1.2.Research assumptions 1.3.Research Methodology 1.3.1.Primary data sources 1.3.2.Secondary data sources 1.4.Key take-aways 1.5.Stakeholders 2.Executive Summary 2.1.Market Definition 2.2.Market Segmentation 3.Specialty Generic Drugs Market Insights 3.1.Specialty Generic Drugs - Industry snapshot 3.2.Specialty Generic Drugs - Ecosystem analysis 3.3.Specialty Generic Drugs market dynamics 3.3.1.Specialty Generic Drugs - Market Forces 3.3.1.1. Specialty Generic Drugs Market driver analysis 3.3.1.2. Specialty Generic Drugs Market restraint/challenges analysis 3.3.1.3. Specialty Generic Drugs Market opportunity analysis 3.3.2.Industry analysis - Porter's five force 3.3.2.1. Bargaining power of supplier 3.3.2.2. Bargaining power of buyers 3.3.2.3. Threat of substitute 3.3.2.4. Threat of new entrants 3.3.2.5. Degree of competition - 4 -

  5. Specialty Generic Drugs Market Size Worth $350.26 Billion By 2028 3.3.3.Specialty Generic Drugs market PEST analysis, 2020 3.3.4.Value Chain Analysis 3.3.5.Specialty Generic Drugs Industry trends 3.3.6.Prevalence of specialty generic drugs 4.Specialty Generic Drugs Market Size and Forecast by Application 4.1.Key findings 4.2.Oncology 4.2.1.Global market estimates and forecasts, 2016 - 2028 4.3.Infectious diseases 4.3.1.Global market estimates and forecasts, 2016 - 2028 4.4.Multiple Sclerosis 4.4.1.Global market estimates and forecasts, 2016 - 2028 4.5.Hepatitis C 4.5.1.Global market estimates and forecasts, 2016 - 2028 4.6.Others 4.6.1.Global market estimates and forecasts, 2016 - 2028 5.Specialty Generic Drugs Market Size and Forecast by Route of Administration 5.1.Key findings 5.2.Oral 5.2.1.Global market estimates and forecasts, 2016 - 2028 5.3.Parenteral 5.3.1.Global market estimates and forecasts, 2016 - 2028 5.4.Topical 5.4.1.Global market estimates and forecasts, 2016 - 2028 5.5.Injectable 5.5.1.Global market estimates and forecasts, 2016 - 2028 5.6.Others 5.6.1.Global market estimates and forecasts, 2016 - 2028 6.Specialty Generic Drugs Market Size and Forecast by Distribution Channel 6.1.Key findings 6.2.Retail Pharmacies 6.2.1.Global market estimates and forecasts, 2016 - 2028 6.3.Hospital Pharmacies 6.3.1.Global market estimates and forecasts, 2016 - 2028 6.4.Online Pharmacies 6.4.1.Global market estimates and forecasts, 2016 - 2028 7.Specialty Generic Drugs Market Size and Forecast by Regions 7.1.Key findings 7.2.North America 7.2.1.Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 7.2.2.Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.2.3.Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 7.2.4.U.S. 7.2.4.1. Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 7.2.4.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.2.4.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 - 5 -

  6. Specialty Generic Drugs Market Size Worth $350.26 Billion By 2028 7.2.5.Canada 7.2.5.1. 7.2.5.2. Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.2.5.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 7.3.Europe 7.3.1.Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 7.3.2.Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.3.3.Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 7.3.4.Germany 7.3.4.1. Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 7.3.4.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.3.4.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 7.3.5.UK 7.3.5.1. Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 7.3.5.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.3.5.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 7.3.6.France 7.3.6.1. Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 7.3.6.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.3.6.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 7.4.Asia Pacific 7.4.1.Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 7.4.2.Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.4.3.Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 7.4.4.China 7.4.4.1. Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 7.4.4.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.4.4.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 7.4.5.India 7.4.5.1. Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 7.4.5.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.4.5.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 7.4.6.Japan 7.4.6.1. Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 - 6 -

  7. Specialty Generic Drugs Market Size Worth $350.26 Billion By 2028 7.4.6.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.4.6.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 7.5.Latin America 7.5.1.Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 7.5.2.Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.5.3.Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 7.5.4.Brazil 7.5.4.1. Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 7.5.4.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.5.4.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 7.5.5.Mexico 7.5.5.1. Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 7.5.5.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.5.5.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 7.6.Middle East & Africa 7.6.1.Specialty Generic Drugs Market by Application (USD Million), 2016 - 2028 7.6.2.Specialty Generic Drugs Market by Route of Administration (USD Million), 2016 - 2028 7.6.3.Specialty Generic Drugs Market by Distribution Channel (USD Million), 2016 - 2028 8.Company Profiles 8.1.Mylan N.V. 8.1.1.Overview 8.1.2.Financials 8.1.3.Product Type Benchmarking 8.1.4.Recent Developments 8.2.Teva Pharmaceuticals USA, Inc. 8.2.1.Overview 8.2.2.Financials 8.2.3.Product Type Benchmarking 8.2.4.Recent Developments 8.3.Sandoz International GmbH 8.3.1.Overview 8.3.2.Financials 8.3.3.Product Type Benchmarking 8.3.4.Recent Developments 8.4.Mallinckrodt, Akorn Inc. 8.4.1.Overview 8.4.2.Financials 8.4.3.Product Type Benchmarking 8.4.4.Recent Developments 8.5.Akorn Inc. - 7 -

  8. Specialty Generic Drugs Market Size Worth $350.26 Billion By 2028 8.5.1.Overview 8.5.2.Financials 8.5.3.Product Type Benchmarking 8.5.4.Recent Developments 8.6.Valeant Pharmaceuticals International Inc. 8.6.1.Overview 8.6.2.Financials 8.6.3.Product Type Benchmarking 8.6.4.Recent Developments 8.7.Endo Pharmaceuticals Inc. 8.7.1.Overview 8.7.2.Financials 8.7.3.Product Type Benchmarking 8.7.4.Recent Developments 8.8.Pfizer Inc. 8.8.1.Overview 8.8.2.Financials 8.8.3.Product Type Benchmarking 8.8.4.Recent Developments 8.9.Sun Pharmaceutical Industries Ltd. 8.9.1.Overview 8.9.2.Financials 8.9.3.Product Type Benchmarking 8.9.4.Recent Developments 8.10. Apotex Corp. 8.10.1.Overview 8.10.2.Financials 8.10.3.Product Type Benchmarking 8.10.4.Recent Developments Access Press Release on Specialty Generic Drugs Market: https://www.polarismarketresearch.com/press-releases/specialty-generic-drugs-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. - 8 -

  9. Specialty Generic Drugs Market Size Worth $350.26 Billion By 2028 E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 9 -

More Related